Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-2 of 2 (Search time: 0.003 seconds).
Issue DateTitleAuthor(s)
2012BIOMARKER (BM) ANALYSES OF A PHASE II STUDY OF NEOADJUVANT PERTUZUMAB AND TRASTUZUMAB WITH AND WITHOUT ANTHRACYCLINE (ATC)-CONTAINING CHEMOTHERAPY FOR TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER (BC) (TRYPHAENA)SCHNEEWEISS, A.; CHIA, S.; HEGG, R.; TAUSCH, C.; DEB, R.; RATNAYAKE, J.; KIERMAIER, A.; MCNALLY, V.; ROSS, G.; CORTES, J.
2012IMMUNOGENICITY OF TRASTUZUMAB INTRAVENOUS AND SUBCUTANEOUS FORMULATIONS IN THE PHASE III HANNAH STUDYHEGG, R.; PIENKOWSKI, T.; CHEN, S.; STAROSLAWSKA, E.; FALCON, S.; KOVALENKO, N.; AL-SAKAFF, N.; HEINZMANN, D.; KOLAITIS, G.; ISMAEL, G.
  • previous
  • 1
  • next